August 3, 2016 by Todd Huseby, Bob O'Meara and Chain Drug Review
A.T. Kearney, Bob O’Meara, community pharmacy, pharmacy retailers, retail pharmacy industry, Todd Huseby
Leading Headlines, Opinion
With massive change in the retail pharmacy industry — including mergers and acquisitions, downward pressure on reimbursement rates, consolidation of payers, and a nascent movement to transform pharmacists into providers — now is a good time to take a step back and look at the big picture. What forces will transform the industry, and which
December 9, 2014 by Khalid Khan, Bob O'Meara and Chain Drug Review
A.T. Kearney, big data, Bob O’Meara, drug adherence, health and wellness, health care delivery, Khalid Khan, pharmacy retailers, retail pharmacies
Issue 12-08-2014, Opinion
Can retail pharmacies beat other players to patient intimacy? Many pharmacy retailers understand that big data can improve business operations, enabling intimate consumer engagement and thereby driving bigger baskets and more door turns, along with healthier customers and margins. They see impacts almost completely confined to the income statement. Too few grasp the strategic ability
August 8, 2014 by Bob O'Meara, Todd Huseby, Jason Dombi and Chain Drug Review
A.T. Kearney, accountable care organization, ACO, Bob O’Meara, e-health, health care, Jason Dombi, pharmacy, retail clinic, telemedicine, Todd Huseby
Issue 08-11-2014, Opinion
It’s Monday morning and you wake up with a throbbing headache, stuffy and dizzy, recognizing that the next thing you absolutely positively need to hear is, “The doctor will see you now.” You roll over in bed, pick up your tablet, open your accountable care organization’s (ACO’s) telemedicine app, and in a few minutes you
June 13, 2014 by Bob O'Meara, Raj Kumar, Vishwa Chandra and Chain Drug Review
Issue 06-16-2014, Opinion
“ ’Twas the night before Black Friday …” No, this isn’t the start to another fairy tale, but rather the time when Amazon threw down the gauntlet, announcing it was working on a drone delivery program. Many have called this one of the best-orchestrated PR events. It brought to the forefront the next delivery frontier —
April 18, 2014 by Bob O'Meara, Adam Pressman and Chain Drug Review
Issue 04-28-2014, Opinion
In today’s hyper-connected, cost-pressured, health-driven environment, there’s no shortage of ideas and issues impacting the health care value chain. Understanding which disruptors are true issues or opportunities and which ones are distractions is a critical element in developing a business strategy. Most of the discussions regarding health care today in the retail pharmacy sector have